CareLit · DOI-Nachweis · Pneumologie
Molecular testing in NSCLC stage IV: why are not 100% of patients tested?
DOI 10.1055/s-0036-1571968
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Lüers, N Neemann, M Hoheisel, K Wedeken, R Prenzel, DC Scriba, K Willborn, U Stropiep, M Tiemann, F Griesinger
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: The current guideline for NSCLC recommends testing for molecular alterations in all non-squamous cell carcinoma patients stage IV and in squamous cell carcinoma patients if they are never or light smokers (< 10 packyears, > 15 years smoking cessation). However, most patients are diagnosed in an in-patient setting for which testing is not yet reimbursed. Therefore, the intention of this study was to ana…
Zitieren
Zitierempfehlung
A Lüers, N Neemann, M Hoheisel, K Wedeken, R Prenzel, DC Scriba, K Willborn, U Stropiep, M Tiemann, F Griesinger (2016) Molecular testing in NSCLC stage IV: why are not 100% of patients tested?. Pneumologie (02). https://doi.org/10.1055/s-0036-1571968
Mit CareLit weiterarbeiten